CN Stock MarketDetailed Quotes

000403 Pacific Shuanglin Bio-pharmacy

Watchlist
  • 21.74
  • +0.05+0.23%
Market Closed Jan 21 15:00 CST
15.89BMarket Cap19.19P/E (TTM)

Pacific Shuanglin Bio-pharmacy Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pacific Shuanglin Bio-pharmacy Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1435.641M / 483.000M--
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1435.641M / 483.000M--

Pacific Shuanglin Bio-pharmacy Earnings Reports

  • Pailin Biotech: Report for the third quarter of 2024

    Oct 27, 2024 12:00 ET

  • Pailin Biotech: Earnings Forecast for the First Three Quarters of 2024

    Oct 9, 2024 12:00 ET

  • Pailin Biotech: 2024 Semi-Annual Report

    Aug 27, 2024 12:00 ET

  • Pailin Biotech: 2024 Semi-Annual Report Summary

    Aug 27, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    HAOMIAO TECHNOLOGY
    831856
    13.12 +22.85%
    Anhui Bossco Environmental Protection Technology
    300422
    5.32 +20.09%
    MH Robot & Automation
    301199
    35.99 +20.01%
    Shanghai Hajime Advanced Material Technology
    301000
    37.79 +20.01%
    ASR Microelectronics
    688220
    64.75 +20.00%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 21, 2025

    Strong Buy

    • Strong Buy

      95.46%

    • Buy

      4.55%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Blood Products Concept
    Blood Products Concept
    Intraday+1.04%
    Shenzhen Stock Exchange
    Shenzhen Stock Exchange
    Intraday+0.28%